8-hydroxy-2,3-dihydro-1H-benzo[d]pyrrolo[1,2-a]imidazol-1-one

ID: ALA1091120

PubChem CID: 46830218

Max Phase: Preclinical

Molecular Formula: C10H8N2O2

Molecular Weight: 188.19

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C1CCc2nc3cccc(O)c3n21

Standard InChI:  InChI=1S/C10H8N2O2/c13-7-3-1-2-6-10(7)12-8(11-6)4-5-9(12)14/h1-3,13H,4-5H2

Standard InChI Key:  JBEAHOTTXSAGKM-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 14 16  0  0  0  0  0  0  0  0999 V2000
    7.7083    1.7791    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1208    3.0500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4558    2.5633    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7901    2.5633    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.5333    1.7791    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1997    1.2925    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.1195    3.8750    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.6109    2.5612    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8713    1.7758    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6800    1.6099    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2291    2.2286    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.9639    3.0157    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1558    3.1778    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8928    3.9597    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  8  4  1  0
  2  3  1  0
  2  7  2  0
  3  1  1  0
  4  5  1  0
  8  9  2  0
  1  5  1  0
  9 10  1  0
 10 11  2  0
  4  2  1  0
 11 12  1  0
  5  6  2  0
 12 13  2  0
 13  8  1  0
  6  9  1  0
 13 14  1  0
M  END

Alternative Forms

Associated Targets(Human)

SF-295 (48000 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
IGROV-1 (47897 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PC-3 (62116 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HOP-62 (47048 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 188.19Molecular Weight (Monoisotopic): 188.0586AlogP: 1.33#Rotatable Bonds:
Polar Surface Area: 55.12Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 8.31CX Basic pKa: 1.86CX LogP: 0.45CX LogD: 0.40
Aromatic Rings: 2Heavy Atoms: 14QED Weighted: 0.68Np Likeness Score: -0.21

References

1. Sondhi SM, Rani R, Singh J, Roy P, Agrawal SK, Saxena AK..  (2010)  Solvent free synthesis, anti-inflammatory and anticancer activity evaluation of tricyclic and tetracyclic benzimidazole derivatives.,  20  (7): [PMID:20188544] [10.1016/j.bmcl.2010.01.147]

Source